CVA Family Office »

Abcellera Biologics shares owned by CVA Family Office

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by CVA Family Office from 13F filings

Historical chart of CVA Family Office investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by CVA Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by CVA Family Office

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3k 230 5.71

More positions owned by CVA Family Office

Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Fds Inf Tech Etf (VGT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Apple (AAPL)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Schwab Strategic Tr Schwb Fdt Emk Lg (FNDE)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)

View all positions for CVA Family Office

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics